Paxman: Acceptance into the FDA’s Safer Technologies Program - Redeye
Börskollen - Aktier, fonder och ekonominyheter
BörskollenFör dig med koll på börsen

Aktieanalys

Paxman: Acceptance into the FDA’s Safer Technologies Program - Redeye

{newsItem.title}

Redeye is positive about the acceptance of Paxman’s PLCS system for CIPN into the FDA’s Safer Technologies Program (SteP). The inclusion reflects FDA recognition of the system’s quality and safety and could simplify the product's regulatory and reimbursement pathways.

Länk till analysen i sin helhet: https://www.redeye.se/research/1131126/paxman-acceptance-into-the-fdas-safer-technologies-program?utm_source=finwire&utm_medium=RSS

Nyheter om Paxman

Läses av andra just nu

Om aktien Paxman

Senaste nytt